植入式心脏监测器(ICM)在不明原因晕厥和心悸中的临床应用和研究进展
Clinical Application and Research Progress of Implantable Heart Monitor (ICM) in Unexplained Syncope and Palpitations
DOI: 10.12677/ACM.2019.911196, PDF,    科研立项经费支持
作者: 张雁飞*, 杨杰孚, 佟佳宾, 种 甲, 刘俊鹏, 王志蕾, 金 鑫, 邹 彤：北京医院，国家老年医学中心，心内科，北京
关键词: 植入式心脏监测器；不明原因晕厥；心悸；ICM；Implantable Heart Monitor； Unexplained Syncope； Palpitation； ICM
摘要: 不明原因晕厥和心悸是心血管系统疾病诊疗中的难点，漏诊误诊率高，临床危害大。目前大多数患者很难通过心电图等常规检查确诊。研究显示，45%~80%的不明原因晕厥可能为心源性晕厥，同时，很多偶发心悸的心律失常患者很难确诊。因此，研究有效的技术手段以提高其诊断率意义重大。近年来，随着植入性心电监测仪(ICM)技术的升级以及相关研究结果的发表，证实其可以显著提高不明原因晕厥和心悸的诊断率。本文对植入式心脏监测器(ICM)在晕厥和心悸中的应用和发展进行概述。
Abstract: Unexplained syncope and palpitation are the difficulties in the diagnosis and treatment of cardiovascular diseases. The rate of missed diagnosis and misdiagnosis is high, which leads to great clinical harm. At present, most patients are difficult to be diagnosed by routine examinations such as electrocardiogram. Studies have shown that 45% to 80% of unexplained syncope may be cardiogenic syncope, and many arrhythmias with occasional palpitations are difficult to diagnose. Therefore, the study of effective technical means to improve its diagnostic rate is of great significance. In recent years, with the development of implantable ECG monitor (ICM) technology and the publication of relevant research results, it has been proved that it can significantly improve the diagnostic rate of syncope and palpitations of unknown causes. This article reviews the application and development of implantable heart monitor (ICM) in syncope and palpitations.
文章引用：张雁飞, 杨杰孚, 佟佳宾, 种甲, 刘俊鹏, 王志蕾, 金鑫, 邹彤. 植入式心脏监测器(ICM)在不明原因晕厥和心悸中的临床应用和研究进展[J]. 临床医学进展, 2019, 9(11): 1266-1275. https://doi.org/10.12677/ACM.2019.911196

参考文献

[1] Raviele, A., Giada, F., Bergfeldt, L., et al. (2011) Management of Patients with Palpitations: A Position Paper from the European Heart Rhythm Association. Europace, 13, 920-934. [Google Scholar] [CrossRef] [PubMed]
[2] Tomson, T.T. and Passman, R. (2017) Current and Emerging Uses of Insertable Cardiac Monitors: Evaluation of Syncope and Monitoring for Atrial Fibrillation. Cardiology in Review, 25, 22-29. [Google Scholar] [CrossRef] 
[3] Soteriades, E.S., Evans, J.C., Larson, M.G., et al. (2002) Incidence and Prognosis of Syncope. The New England Journal of Medicine, 347, 878-885. [Google Scholar] [CrossRef] 
[4] Ganzeboom, K.S., Mairuhu, G., Reitsma, J.B., Linzer, M., Wieling, W. and van Dijk, N. (2006) Lifetime Cumulative Incidence of Syncope in the General Population: A Study of 549 Dutch Subjects Aged 35-60 Years. Journal of Cardiovascular Electrophysiology, 17, 1172-1176. [Google Scholar] [CrossRef] [PubMed]
[5] Patel, P.R. and Quinn, J.V. (2015) Syncope: A Review of Emergency Department Management and Disposition. Clinical and Experimental Emergency Medicine, 2, 67-74. [Google Scholar] [CrossRef] [PubMed]
[6] Kuhne, M., Schaer, B., Sticherling, C. and Osswald, S. (2011) Holter Monitoring in Syncope: Diagnostic Yield in Octogenarians. Journal of the American Geriatrics Society, 59, 1293-1298. [Google Scholar] [CrossRef] [PubMed]
[7] Edvardsson, N., Garutti, C., Rieger, G. and Linker, N.J. (2014) Unexplained Syncope: Implications of Age and Gender on Patient Characteristics and Evaluation, the Diagnostic Yield of an Implantable Loop Recorder, and the Subsequent Treatment. Clinical Cardiology, 37, 618-625. [Google Scholar] [CrossRef] [PubMed]
[8] Edvardsson, N., Frykman, V., van Mechelen, R., et al. (2011) Use of an Implantable Loop Recorder to Increase the Diagnostic Yield in Unexplained Syncope: Results from the PICTURE Regis-try. Europace, 13, 262-269.
[9] Linker, N.J., Voulgaraki, D., Garutti, C., Rieger, G. and Edvardsson, N. (2013) Early versus Delayed Implantation of a Loop Recorder in Patients with Unexplained Syncope—Effects on Care Pathway and Diagnostic Yield. International Journal of Cardiology, 170, 146-151. [Google Scholar] [CrossRef] [PubMed]
[10] Varosy, P.D., Chen, L.Y., Miller, A.L., Noseworthy, P.A., Slot-winer, D.J. and Thiruganasambandamoorthy, V. (2017) Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situa-tional, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm, 14, e255-255e269. [Google Scholar] [CrossRef] 
[11] Brignole, M., et al. (2018) 2018 ESC Guidelines for the Di-agnosis and Management of Syncope. Revista Española de Cardiología, 71, 837. [Google Scholar] [CrossRef] [PubMed]
[12] Sun, B.C. (2013) Quality-of-Life, Health Service Use, and Costs Associated with Syncope. Progress in Cardiovascular Diseases, 55, 370-375. [Google Scholar] [CrossRef] [PubMed]
[13] Golovina, G.A. and Duplyakov, D.V. (2018) Key Points of the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope. Kardiologiia, No. 8, 89-100. [Google Scholar] [CrossRef] 
[14] Brignole, M., Moya, A., de Lange, F.J., et al. (2018) 2018 ESC Guidelines for the Diagnosis and Management of Syncope. European Heart Journal, 39, 1883-1948. [Google Scholar] [CrossRef] [PubMed]
[15] Tomson, T.T. and Passman, R. (2015) The Reveal LINQ Insertable Cardiac Monitor. Expert Review of Medical Devices, 12, 7-18. [Google Scholar] [CrossRef] [PubMed]
[16] Maines, M., Zorzi, A., Tomasi, G., et al. (2018) Clinical Im-pact, Safety, and Accuracy of the Remotely Monitored Implantable Loop Recorder Medtronic Reveal LINQTM. Euro-pace, 20, 1050-1057. [Google Scholar] [CrossRef] [PubMed]
[17] Shen, W.K., Sheldon, R.S., Benditt, D.G., et al. (2017) 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm, 14, e218-218e254.
[18] Krahn, A.D., Klein, G.J., Norris, C. and Yee, R. (1995) The Etiology of Syncope in Patients with Negative Tilt Table and Electrophysiological Testing. Circulation, 92, 1819-1824. [Google Scholar] [CrossRef] 
[19] Krahn, A.D., Klein, G.J., Yee, R. and Skanes, A.C. (2001) Randomized Assessment of Syncope Trial: Conventional Diagnostic Testing versus a Prolonged Monitoring Strategy. Circulation, 104, 46-51. [Google Scholar] [CrossRef] 
[20] Sulke, N., Sugihara, C., Hong, P., Patel, N. and Freemantle, N. (2016) The Benefit of a Remotely Monitored Implantable Loop Recorder as a First Line Investigation in Unexplained Syncope: The EaSyAS II Trial. Europace, 18, 912-918. [Google Scholar] [CrossRef] [PubMed]
[21] Podoleanu, C., DaCosta, A., Defaye, P., et al. (2014) Early Use of an Implantable Loop Recorder in Syncope Evaluation: A Randomized Study in the Context of the French Healthcare System (FRESH Study). Archives of Cardiovascular Diseases, 107, 546-552. [Google Scholar] [CrossRef] [PubMed]
[22] Davis, S., Westby, M., Petkar, S. and Pitcher, D. (2013) Tilt Test-ing Is More Cost-Effective than Implantable Loop Recorder Monitoring as a Means of Directing Pacing Therapy in Peo-ple with Recurrent Episodes of Suspected Vasovagal Syncope That Affect Their Quality of Life or Present a High Risk of Injury. Heart, 99, 805-810. [Google Scholar] [CrossRef] [PubMed]
[23] Farwell, D.J., Freemantle, N. and Sulke, N. (2006) The Clinical Impact of Implantable Loop Recorders in Patients with Syncope. European Heart Journal, 27, 351-356. [Google Scholar] [CrossRef] [PubMed]
[24] Davis, S., Westby, M., Pitcher, D. and Petkar, S. (2012) Implantable Loop Recorders Are Cost-Effective When Used to Investigate Transient Loss of Consciousness Which Is Either Sus-pected to Be Arrhythmic or Remains Unexplained. Europace, 14, 402-409. [Google Scholar] [CrossRef] [PubMed]
[25] Reinsch, N., Ruprecht, U., Buchholz, J., Diehl, R.R., Kalsch, H. and Neven, K. (2018) The BioMonitor 2 Insertable Cardiac Monitor: Clinical Experience with a Novel Implantable Cardiac Monitor. Journal of Electrocardiology, 51, 751-755. [Google Scholar] [CrossRef] [PubMed]
[26] Sanna, T., Diener, H.C., Passman, R.S., et al. (2014) Cryptogenic Stroke and Underlying Atrial Fibrillation. The New England Journal of Medicine, 370, 2478-2486. [Google Scholar] [CrossRef] 
[27] Nakano, Y. and Wataru, S. (2017) Syncope in Patients with Inherited Arrhythmias. Journal of Arrhythmia, 33, 572-578. [Google Scholar] [CrossRef] [PubMed]
[28] Li, Y., Nantsupawat, T., Olson, M., et al. (2018) A Single Center Experience on the Clinical Utility Evaluation of an Insertable Cardiac Monitor. Journal of Electrocardiology, 51, 583-587. [Google Scholar] [CrossRef] [PubMed]
[29] Salvatori, V., Becattini, C., Laureti, S., et al. (2015) Holter Monitoring to Detect Silent Atrial Fibrillation in High-Risk Subjects: The Perugia General Practitioner Study. Internal and Emergency Medicine, 10, 595-601. [Google Scholar] [CrossRef] [PubMed]
[30] Healey, J.S., Connolly, S.J., Gold, M.R., et al. (2012) Subclinical Atrial Fibrillation and the Risk of Stroke. The New England Journal of Medicine, 366, 120-129. [Google Scholar] [CrossRef] 
[31] Passman, R., Leong-Sit, P., Andrei, A.C., et al. (2016) Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment with an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study. Journal of Car-diovascular Electrophysiology, 27, 264-270. [Google Scholar] [CrossRef] [PubMed]
[32] Menozzi, C., Brignole, M., Garcia-Civera, R., et al. (2002) Mechanism of Syncope in Patients with Heart Disease and Negative Electrophysiologic Test. Circulation, 105, 2741-2745. [Google Scholar] [CrossRef] 
[33] Brignole, M., Menozzi, C., Moya, A., et al. (2001) Mechanism of Syncope in Patients with Bundle Branch Block and Negative Electrophysiological Test. Circulation, 104, 2045-2050. [Google Scholar] [CrossRef] [PubMed]
[34] Moya, A., Brignole, M., Menozzi, C., et al. (2001) Mechanism of Syncope in Patients with Isolated Syncope and in Patients with Tilt-Positive Syncope. Circulation, 104, 1261-1267. [Google Scholar] [CrossRef] [PubMed]
[35] Verma, A., Champagne, J., Sapp, J., et al. (2013) Dis-cerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation before and after Catheter Abla-tion (DISCERN AF): A Prospective, Multicenter Study. JAMA Internal Medicine, 173, 149-156. [Google Scholar] [CrossRef] [PubMed]
[36] Yano, Y., Greenland, P., Lloyd-Jones, D.M., Daoud, E.G., Koehler, J.L. and Ziegler, P.D. (2016) Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors. PLoS ONE, 11, e0148914. [Google Scholar] [CrossRef] [PubMed]
[37] Purerfellner, H., Sanders, P., Pokushalov, E., Di, B.M., Berge-mann, T. and Dekker, L.R. (2015) Miniaturized Reveal LINQ Insertable Cardiac Monitoring System: First-in-Human Experience. Heart Rhythm, 12, 1113-1119. [Google Scholar] [CrossRef] [PubMed]
[38] Ritter, M.A., Kochhauser, S., Duning, T., et al. (2013) Occult Atrial Fibrillation in Cryptogenic Stroke: Detection by 7-Day Electrocardiogram versus Implantable Cardiac Monitors. Stroke, 44, 1449-1452. [Google Scholar] [CrossRef] 
[39] Christensen, L.M., Krieger, D.W., Hojberg, S., et al. (2014) Paroxysmal Atrial Fibrillation Occurs Often in Cryptogenic Ischaemic Stroke. Final Results from the SURPRISE Study. European Journal of Neurology, 21, 884-889. [Google Scholar] [CrossRef] [PubMed]
[40] Romanov, A., Martinek, M., Purerfellner, H., et al. (2018) Incidence of Atrial Fibrillation Detected by Continuous Rhythm Monitoring after Acute Myocardial Infarction in Patients with Pre-served Left Ventricular Ejection Fraction: Results of the ARREST Study. Europace, 20, 263-270. [Google Scholar] [CrossRef] [PubMed]
[41] Mascarenhas, D.A., Farooq, M.U., Ziegler, P.D. and Kantharia, B.K. (2016) Role of Insertable Cardiac Monitors in Anticoagulation Therapy in Patients with Atrial Fibrillation at High Risk of Bleeding. Europace, 18, 799-806. [Google Scholar] [CrossRef] [PubMed]
[42] Zuern, C.S., Kilias, A., Berlitz, P., et al. (2015) Anticoagulation after Catheter Ablation of Atrial Fibrillation Guided by Implantable Cardiac Monitors. Pacing and Clinical Electrophysiology: PACE, 38, 688-693. [Google Scholar] [CrossRef] [PubMed]

为你推荐